Cilomilast for COPD : Results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4RENNARD, Stephen I; SCHACHTER, Neil; STREK, Mary et al.Chest. 2006, Vol 129, Num 1, pp 56-66, issn 0012-3692, 11 p.Article

Effects of cilomilast on dendritic cell function in contact sensitivity and dendritic cell migration through skinBÄUMER, Wolfgang; TSCHERNIG, Thomas; SÜLZLE, Boris et al.European journal of pharmacology. 2003, Vol 481, Num 2-3, pp 271-279, issn 0014-2999, 9 p.Article

Warfarin pharmacodynamics unaffected by cilomilastKELLY, John; MURDOCH, Robert D; CLARK, David J et al.The Annals of pharmacotherapy. 2001, Vol 35, Num 12, pp 1535-1539, issn 1060-0280Article

PDE4 inhibitors in COPD: a more selective approach to treatmentVIGNOLA, Antonio Maurizio.Respiratory medicine. 2004, Vol 98, Num 6, pp 495-503, issn 0954-6111, 9 p.Article

TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokinesBÄUMER, W; SEEGERS, U; BRAUN, M et al.British journal of dermatology (1951). 2004, Vol 151, Num 4, pp 823-830, issn 0007-0963, 8 p.Article

Inhibition by Salmeterol and Cilomilast of Fluticasone-Enhanced IP-10 Release in Airway Epithelial CellsREDDY, P. J; AKSOY, Mark O; YI YANG et al.COPD. Journal of chronic obstructive pulmonary disease. 2008, Vol 5, Num 1, pp 5-11, 7 p.Article

Cytokines modulate cilomilast response in lung fibroblastsKOHYAMA, Tadashi; XIANGDE LIU; WEN, Fu-Qiang et al.Clinical immunology (Orlando, Fla. Print). 2004, Vol 111, Num 3, pp 297-302, issn 1521-6616, 6 p.Article

Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxiaWOYDA, K; KOEBRICH, S; GRIMMINGER, F et al.The European respiratory journal. 2009, Vol 33, Num 4, pp 861-870, issn 0903-1936, 10 p.Article

Cilomilast : Orally active selective phosphodiesterase- 4 inhibitor for treatment of chronic obstructive pulmonary diseaseMARTINA, Shaunta D; ISMAIL, Maha S; VESTA, Kimi S et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 10, pp 1822-1828, issn 1060-0280, 7 p.Article

Potentiation and prolongation of long-term odor memory in neonate rats using a phosphodiesterase inhibitorMCLEAN, J. H; DARBY-KING, A; HARLEY, C. W et al.Neuroscience. 2005, Vol 135, Num 2, pp 329-334, issn 0306-4522, 6 p.Article

Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit : Two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteersHOUGHTON, Lesley A; ATKINSON, Wendy; WHORWELL, Peter J et al.Clinical therapeutics. 2006, Vol 28, Num 4, pp 569-581, issn 0149-2918, 13 p.Article

PDE4 inhibitors : current status. CommentaryGIEMBYCZ, M. A; SPINA, D.British journal of pharmacology. 2008, Vol 155, Num 3, issn 0007-1188, 288-290, 308-315 [11 p.]Article

Phosphodiesterase Inhibitors in the Treatment of Inflammatory DiseasesPAGE, C. P; SPINA, D.Handbook of experimental pharmacology. 2011, Vol 204, pp 391-414, issn 0171-2004, 24 p.Article

Phosphodiesterase inhibitors in airways diseaseKIAN FAN CHUNG.European journal of pharmacology. 2006, Vol 533, Num 1-3, pp 110-117, issn 0014-2999, 8 p.Article

Effect of cilomilast (Ariflo) on TNF-α, IL-8, and GM-CSF release by airway cells of patients with COPDPROFITA, M; CHIAPPARA, G; MIRABELLA, F et al.Thorax. 2003, Vol 58, Num 7, pp 573-579, issn 0040-6376, 7 p.Article

Phosphodiesterase 4 inhibitors for the treatment of COPDSTURTON, Graham; FITZGERALD, Mary.Chest. 2002, Vol 121, Num 5, pp 192S-196S, issn 0012-3692Conference Paper

Innovations thérapeutiques dans le traitement de l'asthme et de la BPCO : inhibiteurs des PDE4, atropiniques et corticostéroïdes = New therapeutic agents for the treatment of asthma and COPD : PDE4 inhibitors, atropine derivatives and corticosteroidsDE BLAY, F; BARNIG, C.Revue française d'allergologie et d'immunologie clinique. 2006, Vol 46, Num 3, pp 252-256, issn 0335-7457, 5 p.Conference Paper

Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitisBÄUMER, W; SÜLZLE, B; WEIGT, H et al.British journal of dermatology (1951). 2005, Vol 153, Num 1, pp 136-144, issn 0007-0963, 9 p.Article

Clinical pharmacology of cilomilastDOWN, Geoff; SIEDERER, Sarah; LIM, Sam et al.Clinical pharmacokinetics. 2006, Vol 45, Num 3, pp 217-233, issn 0312-5963, 17 p.Article

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary diseaseGAMBLE, Elizabeth; GROOTENDORST, Diana C; KROEGEL, Claus et al.American journal of respiratory and critical care medicine. 2003, Vol 168, Num 8, pp 976-982, issn 1073-449X, 7 p.Article

New orally active PDE4 inhibitors with therapeutic potentialOCHIAI, Hiroshi; ISHIDA, Akiharu; OHTANI, Tazumi et al.Bioorganic & medicinal chemistry letters (Print). 2004, Vol 14, Num 1, pp 29-32, issn 0960-894X, 4 p.Article

The Efficacy and Safety of Cilomilast in COPDRENNARD, Stephen; KNOBIL, Katharine; RABE, Klaus F et al.Drugs (Basel). 2008, Vol 68, pp 3-57, issn 0012-6667, 55 p., SUP2Article

The phosphodiesterase type IV inhibitor cilomilast decreases pro-inflammatory cytokine production from primary bronchial epithelial cells in lung transplantation patientsMURPHY, Des M; WARD, Chris; FORREST, Ian A et al.The Journal of heart and lung transplantation. 2006, Vol 25, Num 12, pp 1436-1440, issn 1053-2498, 5 p.Article

Benefit of phosphodiesterase 4 inhibitors as supplemental therapy after lung transplantation concerning their antiproliferative effects: An experimental study using a heterotopic rodent modelSCHADE, Ina; ROTH-EICHHORN, Sylke; KASPER, Michael et al.Transplantation. 2002, Vol 74, Num 3, pp 326-334, issn 0041-1337Article

Discovery of selective PDE4B inhibitorsNAGANUMA, Kenji; OMURA, Akifumi; NAKAMURA, Junji et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 12, pp 3174-3176, issn 0960-894X, 3 p.Article